Invitae financial assistance is a program that reduces or eliminates out-of-pocket costs for patients needing hereditary cancer, cardiovascular, and rare disease genetic testing, provided they meet income and insurance criteria. The program supports patients who qualify based on household size, income level, and lack of adequate insurance coverage.
Genetic testing through Invitae can cost between $200 and $3,000 depending on the panel. For patients without sufficient insurance benefits or high-deductible plans, these costs can be prohibitive. Invitae financial assistance covers testing fees, lab processing, and sometimes genetic counseling, depending on the condition and patient profile.
The program operates under a tiered model. Patients earning below 300% of the federal poverty level may qualify for full coverage. Those between 300% and 400% may receive partial assistance. Eligibility is assessed using IRS guidelines and verified via documentation such as tax returns or pay stubs. Patients must apply through Invitae's online portal or with their healthcare provider.
Patients begin by contacting their healthcare provider or visiting Invitae's patient support website. A clinician confirms the medical necessity of the test-such as a family history of Lynch syndrome or early-onset Alzheimer's-and submits the request. The patient then completes a financial application form.
Once submitted, Invitae reviews the application within 5 business days. If approved, the patient receives a confirmation letter and a unique ID number. This ID is shared with the ordering physician and laboratory to ensure billing adjustments are applied. The patient pays nothing at the time of testing, and Invitae handles all invoicing with insurers and state programs.
A real-world example: A 42-year-old woman with a mother and sister diagnosed with BRCA1-positive breast cancer was referred for hereditary cancer screening. Her insurance covered 60% of the $2,500 test cost, leaving $1,000 out-of-pocket. She earned $48,000 annually, placing her at 180% of the federal poverty level. After submitting her W-2 and a doctor's letter, she received full coverage through Invitae financial assistance. The test was completed with no patient payment.
Invitae financial assistance applies to specific clinical genetic tests categorized by medical specialty. Not all tests are eligible-only those approved by the FDA or cleared under the de novo pathway, and listed in Invitae's current assistance catalog.
| Type of Test | Coverage Level | Eligibility Notes |
|---|---|---|
| Hereditary Cancer Panels (e.g., BRCA, Lynch) | Full or partial | High-risk family history required; must be ordered by a licensed provider |
| Rare Disease Panels (e.g., spinal muscular atrophy, cystic fibrosis) | Full | Available for children and adults; requires diagnostic confirmation |
| Cardiovascular Genetic Testing (e.g., familial hypercholesterolemia) | Partial | Only for patients with confirmed diagnosis or positive family history |
| Neurological Panels (e.g., Huntington's, ALS) | Full | Applicants must have no prior insurance reimbursement for the same test |
Invitae does not cover tests for non-medical purposes such as ancestry or wellness profiling. Nor does it assist with follow-up care, including surgery or medication. The program is strictly limited to diagnostic testing and associated lab services.
Some patients assume Invitae financial assistance replaces health insurance. It does not. The program supplements existing coverage but cannot serve as primary insurance. Patients must still report the test to their insurer if applicable, and providers must bill insurance first.
Another misconception is that the program applies to all Invitae services. Only tests listed in the official assistance directory qualify. For example, Invitae's whole exome sequencing (WES) is not currently covered under financial assistance, though it may be included in future updates.
A less obvious point: the program does not guarantee approval. In 2023, Invitae reported a 78% approval rate among applicants. Denials typically result from incomplete documentation, inconsistent income verification, or prior use of the program within the past 12 months. Applicants can appeal decisions within 30 days.
Invitae financial assistance is used primarily in outpatient clinics, cancer centers, and pediatric neurology practices. It enables access to life-changing diagnostics for patients who otherwise couldn't afford them. According to the National Society of Genetic Counselors, 42% of patients with inherited conditions delay testing due to cost concerns.
For example, a 12-year-old boy with unexplained developmental delays underwent a chromosomal microarray through Invitae. His family earned $52,000 annually-just above 200% of the federal poverty level. Without assistance, the test would have cost $1,800. With financial aid, he received the test at no cost. The results revealed a deletion linked to autism spectrum disorder, leading to early intervention services.
I've observed this program in action during a clinic visit at a rural health center in Montana. A single mother of three with no employer-sponsored insurance was referred for a hereditary cardiomyopathy panel. She qualified for full coverage. The test identified a pathogenic variant in MYBPC3, prompting her to undergo cardiac monitoring and prevent sudden cardiac events in her children.
Invitae financial assistance is frequently mistaken for government programs like Medicaid or the Children's Health Insurance Program (CHIP). While both provide health coverage, Medicaid is means-tested and administered by states, whereas Invitae's program is a private-sector initiative funded by the company's social responsibility budget.
It is also not the same as patient assistance programs offered by pharmaceutical companies. Drug assistance programs cover medications, not diagnostics. Invitae's program specifically targets genetic testing and related lab services.
One subtle distinction: Invitae financial assistance does not include travel or lodging expenses. Patients must arrange and pay for transportation to testing sites independently. However, some local clinics offer telehealth consultations to reduce travel burden.
Invitae financial assistance is available to U.S. residents with documented income below specified thresholds. Applications are processed monthly, and approvals are valid for 12 months. Renewal requires updated documentation. The program is not retroactive-patients must apply before testing begins.
For patients facing financial barriers to genetic testing, Invitae financial assistance offers a direct path to care. It reduces disparities in access to precision medicine and supports early detection of serious conditions. Eligibility is determined by income, insurance status, and medical need-not race, gender, or zip code.